PET for drug development.
Halldin
C
C
Karolinska Institute, Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital, Sweden. christer.halldin@ks.se
Gulyás
B
B
Farde
L
L
D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism; D002986:Clinical Trials as Topic; D015195:Drug Design; D006801:Humans; D008024:Ligands; D019275:Radiopharmaceuticals / Q000009:adverse effects / Q000493:pharmacokinetics; D014055:Tomography, Emission-Computed; D015899:Tomography, Emission-Computed, Single-Photon
D008024:Ligands; D019275:Radiopharmaceuticals